Risk Factors and Quality of Life in Women with Urinary Incontinence in Kazakhstan: A Multicenter Case–Control Study
Highlights
- Urinary incontinence represents an underrecognized women’s health problem in Kazakhstan, with important clinical and public health implications.
- The study highlights the burden of UI beyond clinical symptoms, including reduced quality of life and greater impairment among women with urgency urinary incontinence.
- This study provides population-specific evidence from Kazakhstan, where data on UI risk factors and quality-of-life impact remain limited.
- Obstetric and metabolic factors, including vaginal delivery, multiple birth, macrosomia, and overweight or obesity, were independently associated with UI.
- Prevention strategies should integrate weight management, antenatal counseling, postpartum follow-up, and early assessment of pelvic floor dysfunction.
- Further research is needed to improve UI screening, reduce stigma, and develop culturally appropriate public health interventions for women in Kazakhstan.
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Design and Settings
2.2. Data Collection and Training
2.3. Research Tools
2.4. Definitions Used
2.5. Ethical Aspects
2.6. Statistical Analysis
3. Results
4. Discussion
4.1. Risk Factors for UI in the Kazakhstani Female Population
4.2. Quality of Life and Health Policy Priorities in Women with UI
4.3. Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| UI | urinary incontinence |
| SUI | stress urinary incontinence |
| UUI | urgency urinary incontinence |
| MUI | mixed urinary incontinence |
| BMI | body mass index |
| SD | standard deviation |
| ANOVA | analysis of variance |
| I-QOL | Incontinence Quality of Life Questionnaire |
| ALB | avoidance and limiting behavior |
| PS | psychosocial impacts |
| SE | social embarrassment |
Appendix A. STROBE Statement—Checklist for Case–Control Studies
| Section | Item | STROBE Recommendation | Reported on Page/Line | Information Reported in the Manuscript/Response |
|---|---|---|---|---|
| Title and abstract | 1(a) | Indicate the study’s design with a commonly used term in the title or the abstract. | Title; Abstract, lines 2–3; 47–48 | The manuscript title and abstract identify the study as a multicenter case–control study. |
| 1(b) | Provide in the abstract an informative and balanced summary of what was performed and what was found. | Abstract, lines 43–61 | The abstract summarizes the introduction, objective, multicenter case–control design, sample, main associated factors, I-QOL findings, and conclusions. | |
| Introduction | ||||
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported. | Introduction, lines 64–110 | The Introduction describes the burden of urinary incontinence, its effect on women’s quality of life, and the lack of comprehensive evidence from Kazakhstan. |
| Objectives | 3 | State specific objectives, including any prespecified hypotheses. | Introduction, lines 108–110 | The primary aim of the study was to identify factors associated with UI among women in Kazakhstan. The secondary aim was to evaluate clinical characteristics and quality of life according to UI subtype. |
| Methods | ||||
| Study design | 4 | Present key elements of study design early in the paper. | Methods, Study design, lines 115–117 | The study is described as a multicenter age-matched case–control study conducted in Kazakhstan. |
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection. | Methods, Study setting and recruitment, lines 115–117, 138–143, 149–150 | The study was conducted from February to May 2025 in outpatient clinics, family medicine practices, private clinics, and medical offices across 10 cities/regions of Kazakhstan; 28 physicians from 16 institutions collected data. |
| Participants | 6(a) | Give the eligibility criteria, and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controls. | Methods, Participants, lines 122–133 | Eligible participants were women aged ≥18 years who provided written informed consent. Cases were women diagnosed with UI by qualified specialists; controls were women without UI. Exclusion criteria included pregnancy, acute urinary tract infection, advanced pelvic organ prolapse, neurologic bladder disorders, and cognitive impairment. |
| 6(b) | For matched studies, give matching criteria and the number of controls per case. | Methods, Participants/Matching, lines 127–133, 551–552 | Controls were age-matched to cases within +/−2 years at a 1:2 ratio. The limitation that only age was used for matching is acknowledged in the Discussion. | |
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable. | Methods, Variables and definitions, lines 214–220 | UI status, UI subtype, sociodemographic variables, obstetric history, BMI, comorbidities, menopause, heavy lifting, macrosomia (≥4000 g), and quality-of-life domains were defined. Potential confounders included socioeconomic status and parity/delivery-related variables. |
| Data sources/measurement | 8 * | For each variable of interest, give sources of data and details of methods of assessment. Describe comparability of assessment methods if there is more than one group. | Methods, Research tools/Data collection, lines 196–212 | Data were collected using structured questionnaires and the I-QOL instrument. Russian and Kazakh versions were prepared using forward-backward translation, pilot testing, and reliability assessment. Questionnaire administration was standardized through a one-day online training for participating healthcare professionals. |
| Bias | 9 | Describe any efforts to address potential sources of bias. | Methods; Discussion, Limitations | Age matching, standardized data collection forms, training of healthcare professionals, and exclusion criteria were used to reduce bias. |
| Study size | 10 | Explain how the study size was arrived at. | Methods, Sample size, lines 246–251 | A priori sample size estimation was performed for a matched case–control study with a 1:2 case-to-control ratio, assuming a two-sided significance level of 0.05, 80% statistical power, and an expected moderate association between exposure and UI. The estimated minimum sample size was substantially lower than the final study population. Ultimately, the study included 687 matched cases and 1374 matched controls, providing sufficient statistical power for the evaluation of multiple risk factors. |
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why. | Methods, Statistical analysis | Continuous variables were summarized as medians and interquartile ranges. BMI was categorized according to WHO categories; macrosomia and heavy lifting were analyzed using prespecified thresholds. |
| Statistical methods | 12(a) | Describe all statistical methods, including those used to control for confounding. | Methods, Statistical analysis, lines 243–267 | Analyses were performed in SPSS v27. Continuous variables were compared using rank-based tests; categorical variables with chi-square/Fisher’s exact tests. Unadjusted and multivariable logistic regression models with ORs and 95% CIs were used to identify factors associated with UI. |
| 12(b) | Describe any methods used to examine subgroups and interactions. | Methods, Statistical analysis | Subtype analyses were conducted for SUI, UUI, and MUI, including risk-factor distribution and I-QOL domain scores. | |
| 12(c) | Explain how missing data were addressed. | Methods, Data collection, Lines 151–153 | All records were carefully screened, and entries containing technical errors or inappropriate responses were excluded from the analysis. | |
| 12(d) | If applicable, explain how matching of cases and controls was addressed. | Methods, Study Design and Setting, Lines 126–129 | Cases and controls were frequency matched by age to achieve comparable age distributions between the two groups. Age was controlled for by the matching procedure and its distribution was confirmed to be comparable between groups. | |
| 12(e) | Describe any sensitivity analyses. | Methods, Statistical analysis | No sensitivity analysis was performed | |
| Results | ||||
| Participants | 13(a) * | Report numbers of individuals at each stage of study, e.g., potentially eligible, examined for eligibility, confirmed eligible, included, completing follow-up, and analysed. | Materials and Methods; Data collection and Training, Lines 153–161 | A flowchart was added to show recruitment and derivation of the final sample. The final sample included 2061 women: 687 cases with UI and 1374 matched controls. |
| 13(b) * | Give reasons for non-participation at each stage. | Materials and Methods; Data collection and Training, Lines 153–161 | Reasons for exclusion/non-inclusion should be shown in the flowchart, including technical errors, inappropriate responses, and exclusion criteria | |
| 13(c) * | Consider use of a flow diagram. | Materials and Methods; Data collection and Training, Lines 153–161 | The flowchart is present | |
| Descriptive data | 14(a) * | Give characteristics of study participants and information on exposures and potential confounders. | Results, Table 1 and Table 2 | Table 1 and Table 2 present characteristics of cases and matched controls, including sociodemographic, obstetric, clinical, and lifestyle-related variables. |
| 14(b) * | Indicate number of participants with missing data for each variable of interest. | Materials and Methods; Data collection and Training, Lines 153–161 | The flowchart demonstrates the number of participants with missing data | |
| Outcome data | 15 * | Report numbers in each exposure category, or summary measures of exposure. | Results, Table 1 and Table 2 | Exposure/risk-factor distributions are reported for cases and matched controls and, where applicable, by UI subtype. |
| Main results | 16(a) | Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision. Make clear which confounders were adjusted for and why they were included. | Results | Crude ORs with 95% CIs were proceeded |
| 16(b) | Report category boundaries when continuous variables were categorized. | Methods; Results tables | Category boundaries are reported, including BMI categories, age groups if used, macrosomia ≥ 4000 g, and heavy lifting ≥ 10 kg. | |
| 16(c) | If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period. | Not applicable | Not applicable to this case–control study; ORs are reported as measures of association. | |
| Other analyses | 17 | Report other analyses performed, e.g., analyses of subgroups and interactions, and sensitivity analyses. | Results, subtype analysis/I-QOL results | Subtype analyses for SUI, UUI, and MUI and I-QOL domain results are reported. |
| Discussion | ||||
| Key results | 18 | Summarise key results with reference to study objectives. | Discussion, lines 319–388 | UI was identified in 687 women (33.3%). Stress urinary incontinence (SUI) was the most common subtype (n = 356; 51.8%), followed by urgency urinary incontinence (UUI) (n = 191; 27.8%) and mixed urinary incontinence (MUI) (n = 140; 20.4%). UI was independently associated with vaginal delivery (OR = 1.48), multiple birth (OR = 2.26), macrosomia (OR = 1.83), and BMI ≥ 25 kg/m2 (OR = 2.08). UUI showed the greatest burden, including the lowest total I-QOL score [36.4 (23.9–88.6)]. |
| Limitations | 19 | Discuss limitations, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias. | Discussion, Limitations lines 430–452 | Limitations include medical-facility-based recruitment and potential selection bias, age-only matching with residual confounding by socioeconomic status and parity, questionnaire-based data, and possible inter-assessor variability because several healthcare professionals administered/assessed questionnaires after one-day online training. |
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence. | Discussion | The interpretation focuses on associated factors, subtype-specific quality-of-life differences, limitations of case–control inference, and consistency with previous UI literature. |
| Generalisability | 21 | Discuss the generalisability/external validity of the study results. | Discussion, Limitations/Implications | Generalizability to the general female population is limited because participants were recruited through medical settings and specialized UI-care pathways. Findings are most applicable to women attending healthcare institutions in Kazakhstan. |
| Other information | ||||
| Funding | 22 | Give the source of funding and the role of funders for the present study and, if applicable, the original study on which the article is based. | Funding statement | Not applicable |
References
- Pizzol, D.; Demurtas, J.; Celotto, S.; Maggi, S.; Smith, L.; Angiolelli, G.; Trott, M.; Yang, L.; Veronese, N. Urinary incontinence and quality of life: A systematic review and meta-analysis. Aging Clin. Exp. Res. 2021, 33, 25–35. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Haylen, B.T.; de Ridder, D.; Freeman, R.M.; Swift, S.E.; Berghmans, B.; Lee, J.; Monga, A.; Petri, E.; Rizk, D.E.; Sand, P.K.; et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int. Urogynecol. J. 2010, 21, 5–26. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Milsom, I.; Gyhagen, M. The prevalence of urinary incontinence. Climacteric 2019, 22, 217–222. [Google Scholar] [CrossRef] [Scilit]
- Wu, J.M.; Hundley, A.F.; Fulton, R.G.; Myers, E.R. Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet. Gynecol. 2009, 114, 1278–1283. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Hunskaar, S.; Lose, G.; Sykes, D.; Voss, S. The prevalence of urinary incontinence in women in four European countries. BJU Int. 2004, 93, 324–330. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Xue, K.; Palmer, M.H.; Zhou, F. Prevalence and associated factors of urinary incontinence in women living in China: A literature review. BMC Urol. 2020, 20, 159. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Choo, M.S.; Ku, J.H.; Oh, S.J.; Lee, K.S.; Paick, J.S.; Seo, J.T.; Kim, D.Y.; Lee, J.J.; Lee, J.G.; Na, Y.G.; et al. Prevalence of urinary incontinence in Korean women: An epidemiologic survey. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2007, 18, 1309–1315. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wang, Q.; Que, Y.Z.; Wan, X.Y.; Lin, C.Q. Prevalence, Risk Factors, and Impact on Life of Female Urinary Incontinence: An Epidemiological Survey of 9584 Women in a Region of Southeastern China. Risk Manag. Healthc. Policy 2023, 16, 1477–1487. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Abufaraj, M.; Xu, T.; Cao, C.; Siyam, A.; Isleem, U.; Massad, A.; Soria, F.; Shariat, S.F.; Sutcliffe, S.; Yang, L. Prevalence and trends in urinary incontinence among women in the United States, 2005–2018. Am. J. Obstet. Gynecol. 2021, 225, 166.e1–166.e12. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Hammad, F.T. Prevalence, social impact and help-seeking behaviour among women with urinary incontinence in the Gulf countries: A systematic review. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021, 266, 150–156. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sazonova, N.A.; Kiseleva, M.G.; Gadzhieva, Z.K.; Gvozdev, M.Y. Urinary incontinence in women and its impact on quality of life. Urologiia 2022, 136–139. (In Russian) [Google Scholar]
- Sharapatov, Y.; Nurberdiev, A.; Keulimzhayev, N.; Botabayeva, A.; Toleubayev, M.; Dmitriyeva, M.; Zhankina, R. Prevalence of Urinary Incontinence and Overactive Bladder Among Female University Students in Kazakhstan. Epidemiologia 2025, 6, 38. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Gaibullaev, A.A.; Iskandarova, G.T.; Abdurizaev, A.A. Prevalence and risk factors for urinary incontinence in women living in the South Priaralye region. Urologiia 2016, 37–42. (In Russian) [Google Scholar] [PubMed]
- Mukhamejan, M.; Shamshudinov, T.; Alchinbayev, M.; Tabynbayev, N.; Dursun, M.; Kussainova, A.; Kassym, L.; Tsigengagel, O.; Zhambylov, N.; Semenova, Y. Long-Term Epidemiological Trends and Regional Disparities in Male Infertility in Central Asia (1991–2023). Int. J. Environ. Res. Public Health 2026, 23, 466. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bureau of National Statistics of the Agency for Strategic Planning and Reforms of the Republic of Kazakhstan. Fertility. Available online: https://bala.stat.gov.kz/en/rozhdaemost/ (accessed on 19 June 2026).
- Republican Center for Health Development. Stress Urinary Incontinence in Women. Clinical Protocols of the Ministry of Health of the Republic of Kazakhstan—2024. Available online: https://diseases.medelement.com/disease/19037 (accessed on 28 June 2026).
- National Institute for Health and Care Excellence. Urinary Incontinence in Women: Quality Standard QS77. Available online: https://www.nice.org.uk/guidance/qs77 (accessed on 28 June 2026).
- Wacholder, S.; Silverman, D.T.; McLaughlin, J.K.; Mandel, J.S. Selection of controls in case-control studies. II. Types of controls. Am. J. Epidemiol. 1992, 135, 1029–1041. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Patrick, D.L.; Martin, M.L.; Bushnell, D.M.; Yalcin, I.; Wagner, T.H.; Buesching, D.P. Quality of life of women with urinary incontinence: Further development of the incontinence quality of life instrument (I-QOL). Urology 1999, 53, 71–76. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- American College of Obstetricians and Gynecologists. Macrosomia: ACOG Practice Bulletin, Number 216. Obstet. Gynecol. 2020, 135, e18–e35. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Royal College of Obstetricians and Gynaecologists. A–Z of Medical Terms. Available online: https://www.rcog.org.uk/for-the-public/a-z-of-medical-terms/ (accessed on 19 May 2026).
- Centers for Disease Control and Prevention. Adult BMI Categories. Available online: https://www.cdc.gov/bmi/adult-calculator/bmi-categories.html (accessed on 19 May 2026).
- Davis, S.R.; Pinkerton, J.A.; Santoro, N.; Simoncini, T. Menopause—Biology, consequences, supportive care, and therapeutic options. Cell 2023, 186, 4038–4058. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Dietze-Hermosa, M.; Hitchcock, R.; Nygaard, I.E.; Shaw, J.M. Intra-abdominal Pressure and Pelvic Floor Health: Should We Be Thinking About This Relationship Differently? Female Pelvic Med. Reconstr. Surg. 2020, 26, 409–414. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yavuz, M.; Etiler, N. Addressing urinary incontinence by gender: A nationwide population-based study in Turkiye. BMC Urol. 2023, 23, 205. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Felippe, M.R.; Zambon, J.P.; Girotti, M.E.; Burti, J.S.; Hacad, C.R.; Cadamuro, L.; Almeida, F. What Is the Real Impact of Urinary Incontinence on Female Sexual Dysfunction? A Case Control Study. Sex. Med. 2017, 5, e54–e60. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- O’Halloran, T.; Bell, R.J.; Robinson, P.J.; Davis, S.R. Urinary incontinence in young nulligravid women: A cross-sectional analysis. Ann. Intern. Med. 2012, 157, 87–93. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Koli, N.; Parle, D.J.; Pardeshi, D.T. A Survey of Urinary Incontinence in Multigravida Females: A Cross-Sectional Study. Int. J. Health Sci. Res. 2022, 12, 56–61. [Google Scholar] [CrossRef] [Scilit]
- Rijal, C.; Hakim, S. Urinary Incontinence in Women Living in Nursing Homes: Prevalence and Risk Factors. Indones. J. Obstet. Gynecol. 2014, 4, 193–198. [Google Scholar] [CrossRef] [Scilit]
- Zhang, N.; He, Y.; Wang, J.; Zhang, Y.; Ding, J.; Hua, K.Q. Effects of a new community-based reproductive health intervention on knowledge of and attitudes and behaviors toward stress urinary incontinence among young women in Shanghai: A cluster-randomized controlled trial. Int. Urogynecol. J. 2016, 27, 545–553. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Tähtinen, R.M.; Cartwright, R.; Tsui, J.F.; Aaltonen, R.L.; Aoki, Y.; Cárdenas, J.L.; El Dib, R.; Joronen, K.M.; Al Juaid, S.; Kalantan, S.; et al. Long-term Impact of Mode of Delivery on Stress Urinary Incontinence and Urgency Urinary Incontinence: A Systematic Review and Meta-analysis. Eur. Urol. 2016, 70, 148–158. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wesnes, S.L.; Seim, E. Birthweight and urinary incontinence after childbirth: A systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. X 2020, 8, 100115. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zhu, J.; Si, J.; Zhao, L.; Liu, W. Association between infant birthweight and pelvic floor muscle strength: A population-based cohort study. BMC Pregnancy Childbirth 2023, 23, 266. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Progetto Menopausa Italia Study Group. Risk factors for genital prolapse in non-hysterectomized women around menopause. Results from a large cross-sectional study in menopausal clinics in Italy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2000, 93, 135–140. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wang, Q.; Manodoro, S.; Lin, H.; Li, X.; Lin, C.; Jiang, X. Risk Factors and a Predictive Model for Mixed Urinary Incontinence among Parous Women: Insights from a Large-Scale Multicenter Epidemiological Investigation. Digit. Health 2025, 11, 20552076251333661. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sun, Y.; Chen, H.; Bai, Y.; Zhang, T.; Bai, W.; Jiang, B. Ketogenic diet may be a new approach to treatment stress urinary incontinence in obese elderly women: Report of five cases. BMC Womens Health 2022, 22, 402. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Development Initiatives. Kazakhstan Nutrition Profile. Global Nutrition Report. Available online: https://globalnutritionreport.org/resources/nutrition-profiles/asia/central-asia/kazakhstan/ (accessed on 19 June 2026).
- Weinberg, A.E.; Leppert, J.T.; Elliott, C.S. Biochemical Measures of Diabetes are Not Independent Predictors of Urinary Incontinence in Women. J. Urol. 2015, 194, 1668–1674. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kwon, C.S.; Lee, J.H. Prevalence, Risk Factors, Quality of Life, and Health-Care Seeking Behaviors of Female Urinary Incontinence: Results From the 4th Korean National Health and Nutrition Examination Survey VI (2007–2009). Int. Neurourol. J. 2014, 18, 31–36. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Komesu, Y.M.; Schrader, R.M.; Ketai, L.H.; Rogers, R.G.; Dunivan, G.C. Epidemiology of Mixed, Stress, and Urgency Urinary Incontinence in Mid-Aged/Older Women: The Importance of Incontinence History. Int. Urogynecol. J. 2016, 27, 763–772. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Waetjen, L.E.; Liao, S.; Johnson, W.O.; Sampselle, C.M.; Sternfield, B.; Harlow, S.D.; Gold, E.B. Factors Associated with Prevalent and Incident Urinary Incontinence in a Cohort of Midlife Women: A Longitudinal Analysis of Data from the Study of Women’s Health Across the Nation. Am. J. Epidemiol. 2007, 165, 309–318. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Riss, P.; Kargl, J. Quality of life and urinary incontinence in women. Maturitas 2011, 68, 137–142. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Frick, A.C.; Huang, A.J.; Van den Eeden, S.K.; Knight, S.K.; Creasman, J.M.; Yang, J.; Ragins, A.I.; Thom, D.H.; Brown, J.S. Mixed urinary incontinence: Greater impact on quality of life. J. Urol. 2009, 182, 596–600. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Minassian, V.A.; Devore, E.; Hagan, K.; Grodstein, F. Severity of urinary incontinence and effect on quality of life in women by incontinence type. Obstet. Gynecol. 2013, 121, 1083–1090. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Alasmi, R.A.; Saqyan, T.M.B.; Alanazi, L.F.; Alharbi, M.F.; Alashgae, A.F. Urinary incontinence: Comparison study to identify the type, incidence and risk factors between admitted women and the general population in Al-Kharj city, Saudi Arabia. Urol. Ann. 2023, 15, 68–73. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Alonezy, M.F.; Metwally, A.S.; Alhazmi, O.A.; Alrehaili, A.O.; Almohammadi, A.A.; Aljuhani, A.S.; Alharthi, F.A.; Aloufi, N.A. The prevalence and related risk factors of urinary incontinence among adult women in Al medina Al Munawara, Saudi Arabia. Cureus 2024, 16, e64966. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- National Institute for Health and Care Excellence. Pelvic Floor Dysfunction: Prevention and Non-Surgical Management. 2021. Available online: https://www.nice.org.uk/guidance/ng210 (accessed on 19 June 2026).

| Matched Controls (n = 1374) | Cases (n = 687) | p-Value | |
|---|---|---|---|
| Age, years (Me (Q1–Q3)) | 51 (44–61) | 52 (44–61) | 0.517 |
| Residence Type (n, %) | 0.002 | ||
| City | 1023 (74.5%) | 475 (69.1%) | |
| Small town | 127 (9.2%) | 57 (8.3%) | |
| Rural settlement | 224 (16.3%) | 155 (22.6%) | |
| Education (n, %) | <0.001 | ||
| High school | 50 (3.6%) | 29 (4.2%) | |
| College | 287 (20.9%) | 237 (34.5%) | |
| Higher education | 1037 (75.5%) | 421 (61.3%) | |
| Marital status (n, %) | <0.001 | ||
| Single | 138 (10.0%) | 40 (5.8%) | |
| Has a partner | 98 (7.1%) | 49 (7.1%) | |
| Married | 1010 (73.5%) | 494 (71.9%) | |
| Divorced | 98 (7.1%) | 50 (7.3%) | |
| Widow | 30 (2.2%) | 54 (7.9%) | |
| Sexual activity (n, %) | <0.001 | ||
| Several times a week | 265 (19.3%) | 62 (9.0%) | |
| Once a week | 196 (14.3%) | 30 (4.4%) | |
| Several times a month | 327 (23.8%) | 115 (16.7%) | |
| Less than once a month | 174 (12.7%) | 132 (19.2%) | |
| Occasionally, during the year | 130 (9.5%) | 103 (15.0%) | |
| I am not sexually active | 150 (10.9%) | 158 (23.0%) | |
| I prefer not to answer | 132 (9.6%) | 87 (12.7%) |
| Matched Controls (n = 1374) | Cases UI (n = 687) | p-Value | |
|---|---|---|---|
| Parity (n, %) | <0.001 | ||
| 0 | 216 (15.7%) | 43 (6.3%) | |
| 1–2 | 676 (49.2%) | 264 (38.4%) | |
| 3–4 | 406 (29.5%) | 284 (41.3%) | |
| ≥5 | 76 (5.5%) | 96 (14.0%) | |
| Delivery mode (n, %) | <0.001 | ||
| Vaginal delivery | 943 (68.6%) | 531 (77.3%) | |
| Cesarean section | 129 (9.4%) | 50 (7.3%) | |
| Nulliparous (no history of childbirth) | 216 (15.7%) | 43 (6.3%) | |
| Mixed (vaginal and cesarean deliveries) | 86 (6.3%) | 63 (9.2%) | |
| Multiple birth (n, %) | <0.001 | ||
| Yes | 82 (6.0%) | 93 (13.5%) | |
| No | 1076 (78.3%) | 551 (80.2%) | |
| Nulliparous (no history of childbirth) | 216 (15.7%) | 43 (6.3%) | |
| Macrosomia (n, %) | <0.001 | ||
| Yes | 168 (12.2%) | 171 (24.9%) | |
| No | 989 (72.0%) | 473 (68.9%) | |
| Nulliparous (no history of childbirth) | 217 (15.8%) | 43 (6.3%) | |
| BMI (n, %) | <0.001 | ||
| <18.5 | 40 (2.9%) | 12 (1.7%) | |
| 18.5–24.9 | 716 (52.1%) | 225 (32.8%) | |
| 25.0–29.9 | 439 (32.0%) | 321 (46.7%) | |
| >30.0 | 179 (13.0%) | 129 (18.8%) | |
| Heavy lifting (n, %) | <0.001 | ||
| Yes | 954 (69.4%) | 561 (81.7%) | |
| No | 355 (25.8%) | 107 (15.6%) | |
| Not sure | 65 (4.7%) | 19 (2.8%) | |
| Diabetes (n, %) | 0.256 | ||
| Yes | 172 (12.5%) | 69 (10.0%) | |
| No | 1158 (84.3%) | 596 (86.8%) | |
| Not sure | 44 (3.2%) | 22 (3.2%) | |
| Arterial hypertension (n, %) | 0.515 | ||
| Yes | 511 (37.2%) | 238 (34.6%) | |
| No | 789 (57.4%) | 412 (60.0%) | |
| Not sure | 74 (5.4%) | 37 (5.4%) | |
| Pelvic surgery (n, %) | 0.763 | ||
| Yes | 200 (14.6%) | 92 (13.4%) | |
| No | 1146 (83.4%) | 580 (84.4%) | |
| Not sure | 28 (2.0%) | 15 (2.2%) | |
| Back pain (n, %) | 0.426 | ||
| Yes | 450 (32.8%) | 238 (34.6%) | |
| No | 891 (64.8%) | 428 (62.3%) | |
| Not sure | 33 (2.4%) | 21 (3.1%) | |
| Menopause (n, %) | 0.151 | ||
| Yes | 455 (33.1%) | 257 (37.4%) | |
| No | 891 (64.8%) | 416 (60.6%) | |
| Not sure | 28 (2.0%) | 14 (2.0%) |
| Variable | Adjusted OR | 95% CI | p-Value |
|---|---|---|---|
| Vaginal delivery | 1.48 | 1.19–1.85 | <0.001 |
| Multiple birth | 2.26 | 1.64–3.12 | <0.001 |
| Macrosomia | 1.83 | 1.42–2.34 | <0.001 |
| BMI ≥ 25 | 2.08 | 1.71–2.54 | <0.001 |
| SUI (n = 356) | UUI (n = 191) | MUI (n = 140) | Total (n = 687) | p-Value | |
|---|---|---|---|---|---|
| Symptom duration, months Me (Q1–Q3) | 24 (0–48) | 36 (3.5–60) | 24 (2–60) | 24 (1–60) | 0.035 |
| Severity (n, %) | 0.024 | ||||
| Low | 100 (28.1%) | 30 (15.7%) | 36 (25.7%) | 166 (24.2%) | |
| Moderate | 118 (33.1%) | 69 (36.1%) | 49 (35.0%) | 236 (34.4%) | |
| High | 138 (38.8%) | 92 (48.2%) | 55 (39.3%) | 285 (41.5%) | |
| Frequency (n, %) | 0.033 | ||||
| Never | 108 (30.3%) | 39 (20.4%) | 34 (24.3%) | 181 (26.3%) | |
| 1–2 times per month | 40 (11.2%) | 11 (5.8%) | 12 (8.6%) | 63 (9.2%) | |
| Approximately once a week (4 times) | 5 (1.4%) | 4 (2.1%) | 3 (2.1%) | 12 (1.7%) | |
| 2–3 times per week | 6 (1.7%) | 3 (1.6%) | 6 (4.3%) | 15 (2.2%) | |
| Approximately once a day | 38 (10.7%) | 20 (10.5%) | 23 (16.4%) | 81 (11.8%) | |
| 1–2 times per day | 62 (17.4%) | 40 (20.9%) | 27 (19.3%) | 129 (18.8%) | |
| 3–4 times per day | 87 (24.4%) | 69 (36.1%) | 33 (23.6%) | 189 (27.5%) | |
| ≥5 times per day | 10 (2.8%) | 5 (2.6%) | 2 (1.4%) | 17 (2.5%) |
| SUI (n = 356) Me (Q1–Q3) | UUI (n = 191) Me(Q1–Q3) | MUI (n = 140) Me (Q1–Q3) | All Patients with UI (n = 687) Me (Q1–Q3) | p-Value | |
|---|---|---|---|---|---|
| ALB | 46.9 (25.0–93.8) | 37.5 (25.0–84.4) | 37.5 (25.0–93.8) | 40.6 (25.0–90.6) | 0.012 |
| PS | 44.4 (25.0–100.0) | 36.1 (25.0–91.7) | 41.7 (25.0–100.0) | 41.7 (25.0–97.2) | 0.009 |
| SE | 40.0 (25.0–95.0) | 35.0 (25.0–85.0) | 40.0 (25.0–95.0) | 40.0 (25.0–95.0) | 0.019 |
| I-QOL total | 43.2 (26.1–95.5) | 36.4 (23.9–88.6) | 37.5 (25.0–96.1) | 39.8 (25.0–94.3) | 0.009 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Ryspayeva, Z.; Khismetova, Z.; Serikova-Esengeldina, D.; Sharipova, K.; Khamidullina, Z.G.; Khudaykulova, G.; Rahanskaya, Y.; Kozhakhmetova, D.; Akhmetova, K.; Kussainova, A.; et al. Risk Factors and Quality of Life in Women with Urinary Incontinence in Kazakhstan: A Multicenter Case–Control Study. Int. J. Environ. Res. Public Health 2026, 23, 893. https://doi.org/10.3390/ijerph23070893
Ryspayeva Z, Khismetova Z, Serikova-Esengeldina D, Sharipova K, Khamidullina ZG, Khudaykulova G, Rahanskaya Y, Kozhakhmetova D, Akhmetova K, Kussainova A, et al. Risk Factors and Quality of Life in Women with Urinary Incontinence in Kazakhstan: A Multicenter Case–Control Study. International Journal of Environmental Research and Public Health. 2026; 23(7):893. https://doi.org/10.3390/ijerph23070893
Chicago/Turabian StyleRyspayeva, Zhanylsyn, Zaytuna Khismetova, Dinara Serikova-Esengeldina, Khalida Sharipova, Zaituna G. Khamidullina, Gulnara Khudaykulova, Yevgeniya Rahanskaya, Dana Kozhakhmetova, Kamila Akhmetova, Assiya Kussainova, and et al. 2026. "Risk Factors and Quality of Life in Women with Urinary Incontinence in Kazakhstan: A Multicenter Case–Control Study" International Journal of Environmental Research and Public Health 23, no. 7: 893. https://doi.org/10.3390/ijerph23070893
APA StyleRyspayeva, Z., Khismetova, Z., Serikova-Esengeldina, D., Sharipova, K., Khamidullina, Z. G., Khudaykulova, G., Rahanskaya, Y., Kozhakhmetova, D., Akhmetova, K., Kussainova, A., & Kassym, L. (2026). Risk Factors and Quality of Life in Women with Urinary Incontinence in Kazakhstan: A Multicenter Case–Control Study. International Journal of Environmental Research and Public Health, 23(7), 893. https://doi.org/10.3390/ijerph23070893

